Private Equity

Fosun Pharma Bids For KKR-Backed Gland Pharma For $1.5B

by chinamoneynetwork.com posted 4years ago 1066 views
Shanghai Fosun Pharmaceutical (Group) Co. has made a non-binding proposal to buy India's Gland Pharma, which is backed by global private equity giant KKR, the Chinese firm said in a disclosure filing.